Medical Device Market Entry in India: A Complete Regulatory Strategy

The Central Drugs Standard Control Organization (CDSCO) is India’s central regulatory authority for medical devices.

Medical devices in India are regulated primarily under the Medical Devices Rules, 2017, along with applicable amendments, notifications, standards, and regulatory requirements.

Before launching a device, manufacturers should determine:

• Whether the product falls within India’s medical device regulatory framework
• The applicable device classification
• Whether a manufacturing or import license is required
• Applicable technical and quality requirements
• Required documentation
• Whether clinical investigation or evaluation requirements apply
• Local representation requirements for foreign manufacturers

Understanding these requirements at the beginning can prevent unnecessary delays during the market entry process.

Step 1: Determine the Medical Device Classification

Device classification is one of the first regulatory steps.

The classification of a medical device in India is based on factors such as its intended purpose, duration of use, invasiveness, and associated risk.

Medical devices are generally classified into:

• Class A: Low risk
• Class B: Low-moderate risk
• Class C: Moderate-high risk
• Class D: High risk

The classification can directly affect the applicable licensing authority, documentation, quality requirements, and regulatory pathway.

Therefore, manufacturers should establish the correct classification before preparing their regulatory submission.

Step 2: Identify the Applicable CDSCO License

After determining the device classification, the manufacturer should identify the applicable regulatory pathway.

For imported medical devices, an appropriate CDSCO import license may be required.

For companies manufacturing medical devices in India, the applicable CDSCO manufacturing license needs to be determined based on the device and manufacturing activity.

The regulatory submission may involve information relating to:

• Product details
• Intended use
• Device classification
• Manufacturing site
• Quality management system
• Technical documentation
• Risk management
• Testing and performance data
• Labeling and packaging
• Post-market information

Operon Strategist supports manufacturers with CDSCO medical device registration and licensing.

Step 3: Foreign Manufacturers Need Local Representation

International manufacturers entering India need to consider their local regulatory representation.

Depending on the applicable regulatory pathway, a foreign manufacturer may need to appoint an Indian Authorized Agent (IAA) to act as its representative for regulatory activities in India.

The local representative can assist with communication with the regulatory authority and regulatory submissions.

Choosing an experienced regulatory partner is therefore an important part of an international company’s medical device market entry in India strategy.

Step 4: Prepare Regulatory Documentation

Regulatory documentation is a critical component of the CDSCO submission.

Depending on the device and applicable requirements, documentation may include:

• Device description
• Intended use
• Device classification rationale
• Manufacturing information
• Quality management documentation
• Risk management documentation
• Product specifications
• Test reports
• Clinical or performance information, where applicable
• Labeling and packaging information
• Existing international regulatory approvals, where applicable

The documentation should be consistent across the regulatory submission, product labeling, technical documentation, and other supporting records.

Step 5: Establish a Quality Management System

A suitable Quality Management System (QMS) is an important part of medical device manufacturing and regulatory compliance.

Manufacturers may need to demonstrate compliance with applicable quality requirements depending on the device, manufacturing activity, and regulatory pathway.

ISO 13485 is widely used as the quality management standard for medical device organizations.

A properly implemented QMS can help manufacturers establish controlled processes for:

• Design and development
• Production
• Supplier management
• Risk management
• Document control
• Validation
• Corrective and preventive actions
• Complaint handling
• Post-market activities
  
  

Operon Strategist provides ISO 13485 consulting and QMS implementation support for medical device manufacturers.

Step 6: Plan Your Distribution Strategy

Regulatory approval is only one part of entering the Indian market.

Manufacturers should also develop a commercial and distribution strategy based on their target customers.

Potential channels include:

• Hospitals
• Clinics
• Diagnostic laboratories
• Medical distributors
• Government healthcare institutions
• Medical equipment suppliers
• Specialty healthcare networks
• Online channels, where appropriate
  
  

For international manufacturers, partnering with experienced Indian distributors can help with local market knowledge, logistics, customer relationships, and after-sales support.

Step 7: Adapt Your Product and Marketing Strategy

India is a diverse market, and a product that performs well in another country may require adjustments for the local market.

Companies should evaluate:

• Pricing
• Product configuration
• Packaging
• Labeling
• User instructions
• Training requirements
• Distribution coverage
• After-sales service
• Local customer support

Healthcare professionals and distributors should also receive appropriate product training, particularly for complex or high-risk medical devices.

Step 8: Plan for Post-Market Compliance

Market entry does not end when the device receives its regulatory authorization.

Manufacturers must continue to monitor product performance and comply with applicable post-market requirements.

Depending on the device and applicable regulations, companies may need processes for:

• Complaint handling
• Adverse event reporting
• Corrective actions
• Product recalls
• Post-market surveillance
• Regulatory record maintenance
• License maintenance and updates

A post-market compliance strategy should therefore be included in the market entry plan from the beginning.